ACR24 JAK_TYK Topic Panel
Rheumnow Podcast
Intro
This chapter features a panel discussion on key findings from ACR 2024 regarding Upadacitinib, a Janus kinase inhibitor, and its effectiveness in treating giant cell arteritis. The conversation includes insights from a randomized controlled trial that showcases improved remission rates and highlights the importance of safety in new treatment approaches.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
